LevoCept

For Women

Clinical Trial Information

Sebela Pharmaceuticals is undergoing Phase 2 Clinical Trials in the United States. To learn more, please visit https://clinicaltrials.gov/ct2/show/NCT02882191.

Clinical Study Title:  Evaluation of the Efficacy and Safety of LevoCept

ClinicalTrials.gov Identifier:  NCT02882191

 

CAUTION: Limited by Federal Law to Investigational Use.